Our MDM2-p53 antagonist showed a manageable safety profile and encouraging signs of efficacy in this @CD_AACR publication from an open-label, first-in-human, Phase Ia/Ib study in people with advanced solid tumors and MDM2 amplification. Further investigations are ongoing. #ASCO23
In honor of #WorldMentalHealthDay, join us on our mission to evolve mental health to enable people to thrive. Learn more about the research we are pursuing at Boehringer Ingelheim. https://t.co/4BUCWGJd7W
This #SarcomaAwarenessMonth, we are sharing the perspectives of #sarcoma patients, specialists and researchers. Mehdi Lahmar our Clinical Program Leader in Oncology, shares the research in this space that we are undertaking, hoping to transform the lives of people with cancer.
We believe collaborating with patients on clinical trial design provides the best experience for participants and can help to bring innovative therapies to patients faster. #InternationalClinicalTrialsDay#ICTD2022
#PRESS: In 2021, we invested 4.1 billion EUR in #research and development. More than 52,000 employees are working on breakthrough therapies that improve the lives of humans and animals in a sustainable way. How did we do in other areas? See here 👉 https://t.co/0JS5VXCOJB
Learn more about how we are applying neurobiology principles to find answers to unsolved areas of mental illness. Dr Hugh Marston and Dr Vikas Mohan Sharma discuss how bringing greater precision to #psychiatry can help us achieve this. #BrainAwarenessWeek
Das BAH-Mitgliedsunternehmen @BoehringerDE stellt nachhaltige Produkte her. Es entstehen weniger Emissionen und weniger Abfälle. Mehr Infos: https://t.co/loGiC3SRac #Nachhaltigkeit
#DYK that a horse's movement can stimulate circuits in the human brain? Together with @equiphoria, we're researching the effect of #hippotherapy on individuals recovering from stroke: ➡️ https://t.co/78TdrMrIcy #OneHealth
BREAKING: JOE BIDEN WINS
Joe Biden will be the 46th president of the United States, CNN projects, after a victory in Pennsylvania puts the Scranton-born Democrat over 270 https://t.co/qLSDFouqPd #CNNElection
Ein großes Danke an alle Unterstützer unserer „Herzenssache Lebenszeit“ Initiative. Wir blicken auf die Auftakt #Pressekonferenz zurück. #Diabetes#Schlaganfall